title: Expression, localisation and functional activation of NFAT-2 in normal human skin, psoriasis, and cultured keratocytes.
abstract: Ciclosporin A (CsA) is widely utilized for the treatment of inflammatory skin diseases such as psoriasis. The therapeutic effects of CsA are thought to be mediated via its immunosuppressive action on infiltrating lymphocytes in skin lesions. CsA and tacrolimus block T cell activation by inhibiting the phosphatase calcineurin and preventing translocation from the cytoplasm to the nucleus of the transcription factor Nuclear Factor of Activated T cells (NFAT). As calcineurin and NFAT 1 have been shown to be functionally active in cultured human keratocytes, expression of other NFAT family members such as NFAT-2 and possible functional activation was investigated in human keratocytes. RT-PCR and Western Analysis were used to investigate the presence of NFAT-2 mRNA and protein in human keratocytes. Tissue culture of human keratocytes and immunostaining of cells on coverslips and confocal microscopy were used to assess the degree of nuclear localisation of NFAT-2 in cultured cells. Keratome biopsies were taken from patients with psoriasis (lesional and non-lesional skin) and normal skin and immunohistochemistry was used to assess the NFAT-2 localisation in these biopsies using a well characterized anti-NFAT-2 antibody. The NFAT-2 mRNA and protein expression was demonstrated using RT-PCR and Western blotting. Moreover, the expression of NFAT-2 in normal skin, non-lesional and lesional psoriasis showed a striking basal staining suggesting a role for NFAT-2 in keratocytes proliferation. A range of cell types in the skin express NFAT-2. The expression of NFAT-2 in human keratocytes and response to different agonists provides perhaps a unique opportunity to examine the regulation, subcellular localization and kinetics of translocation of different NFATs in primary cultured human cells. In these experiments the author assessed the expression, localization of NFAT-2 in cultured human keratocytes and measured the degree of nuclear localisaion of NFAT-2 using immunofluorescence and confocal microscopy and whether CsA and tacrolimus inhibit NFAT-2 nuclear translocation. As with NFAT 1, differentiation-promoting agents that increase intracellular calcium concentration induced nuclear translocation of NFAT-2 in cultured keratocytes but with different kinetics. These data provide the first evidence of that NFAT-2 is expressed in normal skin, psoriasis and that NFAT-2 functionally active in human keratocytes and that nuclear translocation of NFAT-2 in human skin cells has different kinetics than NFAT 1 suggesting that NFAT-2 may play an important role in regulation of keratocytes proliferation and differentiation at a different stage. Inhibition of this pathway in human epidermal keratocytes many account, in part for the therapeutic effects of CsA and tacrolimus in skin disorders such as psoriasis. Thus, supporting our previous work data that calcineurin/NFAT is functionally active not only in T cells, but in skin cells.
authors.forename: Wael I
authors.initials: WI
authors.lastname: Al-Daraji
authors.forename: Tamer T
authors.initials: TT
authors.lastname: Malak
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Prescott
authors.forename: Adel
authors.initials: A
authors.lastname: Abdellaoui
authors.forename: Mahmud M
authors.initials: MM
authors.lastname: Ali
authors.forename: Tarek
authors.initials: T
authors.lastname: Dabash
authors.forename: Bettina G
authors.initials: BG
authors.lastname: Zelger
authors.forename: Bernhard
authors.initials: B
authors.lastname: Zelger
references.citation: Mol Cell Biol. 1995 May;15(5):2697-706
references.pmid: 7739550
references.citation: Arch Dermatol Res. 1994;286(2):123-9
references.pmid: 8154925
references.citation: Cell Immunol. 1991 Apr 1;133(2):269-84
references.pmid: 1707760
references.citation: Dermatologica. 1990;181(2):117-21
references.pmid: 2242778
references.citation: J Clin Endocrinol Metab. 1989 Apr;68(4):851-4
references.pmid: 2921314
references.citation: Br J Dermatol. 1997 May;136(5):666-73
references.pmid: 9205496
references.citation: Immunity. 1995 May;2(5):461-72
references.pmid: 7749981
references.citation: Nature. 1997 Apr 24;386(6627):855-8
references.pmid: 9126747
references.citation: Blood. 1998 Apr 1;91(7):2223-30
references.pmid: 9516119
references.citation: J Biol Chem. 1996 Aug 23;271(34):20914-21
references.pmid: 8702849
references.citation: Immunol Today. 1994 Jun;15(6):274-81
references.pmid: 8068174
references.citation: J Immunol. 1997 Sep 15;159(6):2735-40
references.pmid: 9300694
references.citation: Cell Regul. 1990 Nov;1(12):965-73
references.pmid: 1712634
references.citation: Mol Cell Biol. 2000 Sep;20(17):6600-11
references.pmid: 10938134
references.citation: Nature. 1998 Mar 12;392(6672):182-6
references.pmid: 9515963
references.citation: Immunity. 1998 Jan;8(1):115-24
references.pmid: 9462517
references.citation: Mol Cell Biol. 1997 Apr;17(4):2066-75
references.pmid: 9121455
references.citation: Brain Res. 1987 May 12;411(1):120-8
references.pmid: 2886179
references.citation: Arch Dermatol Res. 1993;284(8):445-50
references.pmid: 8466281
references.citation: Nature. 1995 Apr 13;374(6523):617-22
references.pmid: 7715701
references.citation: Mol Biol Cell. 1998 Oct;9(10):2905-16
references.pmid: 9763451
references.citation: Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9575-80
references.pmid: 11493684
references.citation: Neurochem Int. 1995 Feb;26(2):135-43
references.pmid: 7599534
references.citation: J Dermatol Sci. 1994 Jul;7 Suppl:S47-54
references.pmid: 7528050
references.citation: J Immunol. 1990 Jan 1;144(1):251-8
references.pmid: 1688572
references.citation: Annu Rev Immunol. 1997;15:707-47
references.pmid: 9143705
references.citation: J Invest Dermatol. 1993 Dec;101(6):858-63
references.pmid: 8245514
references.citation: J Virol. 2001 Mar;75(6):3034-7
references.pmid: 11222731
references.citation: Mol Cell. 1998 Apr;1(5):627-37
references.pmid: 9660947
references.citation: Am J Pathol. 1998 Jul;153(1):39-45
references.pmid: 9665463
references.citation: J Biol Chem. 2000 May 12;275(19):14708-16
references.pmid: 10799559
references.citation: J Cell Sci. 1988 Aug;90 ( Pt 4):525-9
references.pmid: 2473085
references.citation: J Invest Dermatol. 1993 Jan;100(1):3-9
references.pmid: 8423390
references.citation: Cell. 1977 Jun;11(2):417-22
references.pmid: 890737
references.citation: Nature. 1993 Sep 23;365(6444):352-5
references.pmid: 8397339
references.citation: J Exp Med. 2000 Jan 3;191(1):9-22
references.pmid: 10620601
references.citation: J Exp Med. 1997 Jan 6;185(1):43-53
references.pmid: 8996240
references.citation: J Dermatol. 1991 May;18(5):252-7
references.pmid: 1939851
references.citation: J Exp Med. 1998 Jun 15;187(12):2031-6
references.pmid: 9625762
references.citation: J Cell Biol. 1978 Mar;76(3):705-11
references.pmid: 24643
references.citation: Br J Dermatol. 1995 Aug;133(2):157-67
references.pmid: 7547380
references.citation: Am J Pathol. 1995 Sep;147(3):718-27
references.pmid: 7677183
references.citation: Immunity. 1998 Nov;9(5):627-35
references.pmid: 9846484
references.citation: Nature. 1997 Apr 17;386(6626):728-31
references.pmid: 9109491
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15537-41
references.pmid: 9861004
references.citation: Nature. 1996 Oct 31;383(6603):837-40
references.pmid: 8893011
references.citation: J Exp Med. 1996 Jul 1;184(1):141-7
references.pmid: 8691127
references.citation: J Immunol. 1999 Jun 15;162(12):7294-301
references.pmid: 10358178
references.citation: Mol Cell Endocrinol. 2001 May 25;177(1-2):161-71
references.pmid: 11377831
references.citation: J Immunol. 1990 Feb 15;144(4):1418-24
references.pmid: 1689353
references.citation: Cancer Res. 1983 Sep;43(9):4443-7
references.pmid: 6307514
references.citation: Br J Dermatol. 1998 Jul;139(1):16-22
references.pmid: 9764143
references.citation: Immunity. 1998 Sep;9(3):295-304
references.pmid: 9768749
references.citation: J Invest Dermatol. 1992 Aug;99(2):193-200
references.pmid: 1629632
references.citation: Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8298-302
references.pmid: 1381508
references.citation: Immunity. 1997 Apr;6(4):361-9
references.pmid: 9133415
references.citation: J Immunol. 1989 Jul 15;143(2):718-26
references.pmid: 2472451
references.citation: Nature. 1992 Jun 25;357(6380):695-7
references.pmid: 1377362
references.citation: Immunity. 1998 Jan;8(1):125-34
references.pmid: 9462518
references.citation: J Biol Chem. 2000 Mar 31;275(13):9143-9
references.pmid: 10734048
references.citation: J Exp Med. 1996 Jul 1;184(1):101-12
references.pmid: 8691123
references.citation: Immunol Lett. 2001 Mar 1;76(2):133-8
references.pmid: 11274732
references.citation: Cell. 1999 Mar 5;96(5):611-4
references.pmid: 10089876
references.citation: Immunity. 2000 Apr;12(4):359-72
references.pmid: 10795734
references.citation: EMBO J. 1997 Aug 15;16(16):4983-98
references.pmid: 9305640
references.citation: Immunity. 1999 Feb;10(2):261-9
references.pmid: 10072078
references.citation: Front Biosci. 2000 Feb 01;5:D268-83
references.pmid: 10704155
references.citation: Cell. 1998 Apr 17;93(2):215-28
references.pmid: 9568714
references.citation: Science. 1996 Dec 13;274(5294):1903-5
references.pmid: 8943202
references.citation: Annu Rev Biochem. 1994;63:1045-83
references.pmid: 7979236
references.citation: Cancer Res. 1986 Apr;46(4 Pt 2):2068-71
references.pmid: 2418960
references.citation: Mol Cell Biol. 1996 Jul;16(7):3945-54
references.pmid: 8668212
references.citation: Pathobiology. 1992;60(2):93-9
references.pmid: 1571097
references.citation: EMBO J. 1996 Sep 2;15(17):4526-36
references.pmid: 8887544
references.citation: J Invest Dermatol. 1993 May;100(5):613-7
references.pmid: 8098344
references.citation: Immunity. 1997 Mar;6(3):235-44
references.pmid: 9075924
references.citation: Mol Cell Biol. 1997 May;17(5):2475-84
references.pmid: 9111316
references.citation: Nature. 1996 Jul 25;382(6589):370-3
references.pmid: 8684469
references.citation: Nature. 1998 Mar 12;392(6672):186-90
references.pmid: 9515964
references.citation: Int J Dermatol. 1985 Oct;24(8):507-8
references.pmid: 2415474
references.citation: J Virol. 2001 Oct;75(20):9955-65
references.pmid: 11559828
references.citation: EMBO J. 1990 Sep;9(9):2877-84
references.pmid: 2118107
references.citation: Clin Exp Dermatol. 2002 Oct;27(7):555-61
references.pmid: 12464150
references.citation: Nature. 1998 Mar 5;392(6671):42-8
references.pmid: 9510247
references.citation: Immunity. 1997 Dec;7(6):849-60
references.pmid: 9430230
references.citation: Immunity. 1999 May;10(5):515-24
references.pmid: 10367897
references.citation: Cell. 1979 Nov;18(3):681-94
references.pmid: 42494
references.citation: Biochem Soc Trans. 1997 May;25(2):347-54
references.pmid: 9191115
references.citation: J Invest Dermatol. 1993 Nov;101(5):732-7
references.pmid: 8228336
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8907-12
references.pmid: 8799126
references.citation: J Invest Dermatol. 2002 May;118(5):779-88
references.pmid: 11982754
references.citation: Science. 1996 May 10;272(5263):892-5
references.pmid: 8629027
references.citation: Curr Opin Cell Biol. 1993 Feb;5(1):70-6
references.pmid: 8448032